[
  {
    "patient_ID": "TCGA.2Z.A9J3",
    "drug_therapy_name": "SUNITINIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 83,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 295,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.2Z.A9J3",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 829,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1058,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.2Z.A9J3",
    "drug_therapy_name": "SUNITINIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1058,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1765,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.4A.A93X",
    "drug_therapy_name": "SUNITINIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.A4.7287",
    "drug_therapy_name": "CISPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 254,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 282,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.A4.7287",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 254,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 436,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.A4.7287",
    "drug_therapy_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 290,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 436,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.A4.A57E",
    "drug_therapy_name": "EVEROLIMUS",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.AL.3466",
    "drug_therapy_name": "INTERFERON",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 138,
    "drug_units": "M[IU]",
    "drug_dose": 10,
    "regimen_number": 1,
    "drug_route": "SUBCUTANEOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.AL.A5DJ",
    "drug_therapy_name": "TEMSIROLIMUS",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 355,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 475,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.B9.4114",
    "drug_therapy_name": "PAZOPANIB",
    "days_to_drug_start": 722,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 755,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.B9.4114",
    "drug_therapy_name": "SUNITINIB",
    "days_to_drug_start": 779,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.BQ.5877",
    "drug_therapy_name": "TANESPIMYCIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 123,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 220,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "METASTASIS"
  },
  {
    "patient_ID": "TCGA.BQ.5878",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1086,
    "pharmaceutical_tx_ongoing": true,
    "drug_units": "MG",
    "drug_dose": 400,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER"
  },
  {
    "patient_ID": "TCGA.BQ.5879",
    "drug_therapy_name": "SUNITINIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 192,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 430,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_dose": 25,
    "regimen_number": 1,
    "drug_route": "ORAL"
  },
  {
    "patient_ID": "TCGA.BQ.5879",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 508,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 591,
    "drug_units": "MG",
    "drug_dose": 400,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PREVIOUS TRIAL CLOSED, PRESCRIBED NEW MEDICAL TREATMENT"
  },
  {
    "patient_ID": "TCGA.BQ.5879",
    "drug_therapy_name": "TEMSIROLIMUS",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 472,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 493,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_dose": 15,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.BQ.5879",
    "drug_therapy_name": "SUNITINIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 472,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 493,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_dose": 25,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.BQ.5879",
    "drug_therapy_name": "TEMSIROLIMUS",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 612,
    "pharmaceutical_tx_ongoing": false,
    "drug_units": "MG",
    "drug_dose": 25,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.BQ.5879",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 192,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 430,
    "drug_cycles": 6,
    "drug_units": "MG/KG",
    "drug_dose": 25,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER"
  },
  {
    "patient_ID": "TCGA.BQ.5889",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 258,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 329,
    "drug_units": "MG",
    "drug_dose": 400,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.BQ.5889",
    "drug_therapy_name": "SUNITINIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 175,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 241,
    "drug_units": "MG",
    "drug_dose": 50,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.BQ.5889",
    "drug_therapy_name": "TEMSIROLIMUS",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 169,
    "drug_units": "MG",
    "drug_dose": 25,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "METASTASIS"
  },
  {
    "patient_ID": "TCGA.BQ.5893",
    "drug_therapy_name": "EVEROLIMUS",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 183,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_dose": 10,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER"
  },
  {
    "patient_ID": "TCGA.BQ.7048",
    "drug_therapy_name": "TEMSIROLIMUS",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2146,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2398,
    "drug_units": "MG",
    "drug_dose": 25,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.BQ.7048",
    "drug_therapy_name": "SUNITINIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 2042,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2146,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_dose": 37.5,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.BQ.7048",
    "drug_therapy_name": "PSMA DNA VACCINE",
    "pharmaceutical_therapy_type.1": "OTHER",
    "days_to_drug_start": 495,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 915,
    "pharma_type_other": "VACCINE",
    "drug_dose": 1500,
    "regimen_number": 1,
    "drug_route": "INTRAMUSCULAR",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.BQ.7048",
    "drug_therapy_name": "SUNITINIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1880,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2042,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_dose": 50,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.BQ.7056",
    "drug_therapy_name": "TEMSIROLIMUS",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 638,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 730,
    "drug_units": "MG",
    "drug_dose": 25,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "METASTASIS"
  },
  {
    "patient_ID": "TCGA.BQ.7056",
    "drug_therapy_name": "SUNITINIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 759,
    "drug_units": "MG",
    "drug_dose": 37.5,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER"
  },
  {
    "patient_ID": "TCGA.BQ.7058",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 216,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 295,
    "drug_units": "MG",
    "drug_dose": 400,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER"
  },
  {
    "patient_ID": "TCGA.BQ.7058",
    "drug_therapy_name": "TEMSIROLIMUS",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 302,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 302,
    "drug_units": "MG",
    "drug_dose": 25,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.BQ.7058",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 203,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 216,
    "drug_units": "MG",
    "drug_dose": 800,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER"
  },
  {
    "patient_ID": "TCGA.G7.6789",
    "drug_therapy_name": "INTERFERON ALFA 2B",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 74,
    "drug_cycles": 2,
    "regimen_number": 1,
    "drug_route": "SUBCUTANEOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.G7.6793",
    "drug_therapy_name": "TEMSIROLIMUS",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 258,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 25,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 700
  },
  {
    "patient_ID": "TCGA.G7.6793",
    "drug_therapy_name": "SUNITINIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 260,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 287,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_dose": 50,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.G7.7501",
    "drug_therapy_name": "SUNITINIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 110,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 506,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.G7.A8LD",
    "drug_therapy_name": "EVEROLIMUS",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 424,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 446,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.G7.A8LD",
    "drug_therapy_name": "SUNITINIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 340,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 417,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.GL.7966",
    "drug_therapy_name": "SUNITINIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 96,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.IA.A83W",
    "drug_therapy_name": "RITUXIMAB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 496,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 601,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.IA.A83W",
    "drug_therapy_name": "VINCRISTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 496,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 601,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.IA.A83W",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 496,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 601,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.IA.A83W",
    "drug_therapy_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 496,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 601,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.MH.A855",
    "drug_therapy_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 86,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 205,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.MH.A855",
    "drug_therapy_name": "PEMETREXED",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 86,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 205,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.SX.A7SM",
    "drug_therapy_name": "PAZOPANIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 66,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 362,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  }
]
